PLX Total Non-Current Liabilities
Protalix Biotherapeutics Inc · Total Non-Current Liabilities
PLX Total Non-Current Liabilities
Latest reported$7.54Mperiod ending
PLX Quarterly Total Non-Current Liabilities ($7.30M → $7.54M)
Quarterly total non-current liabilities
High-resolution chart · PNG
PLX total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 7,541,000 | |
| 7,718,999 | |
| 7,598,000 | |
| 7,411,000 | |
| 4,492,000 | |
| 4,362,000 | |
| 4,585,000 | |
| 4,906,000 | |
| 4,987,000 | |
| 5,211,000 | |
| 5,335,000 | |
| 5,963,000 | |
| 26,307,000 | |
| 34,036,000 | |
| 33,998,000 | |
| 33,921,000 | |
| 39,569,000 | |
| 40,546,000 | |
| 46,525,000 | |
| 40,505,000 | |
| 8,116,000 | |
| 7,427,000 | |
| 8,497,000 | |
| 61,729,999 | |
| 64,059,000 | |
| 66,129,000 | |
| 75,539,000 | |
| 91,259,000 | |
| 96,734,000 | |
| 93,863,000 | |
| 88,659,000 | |
| 117,640,000 | |
| 86,220,000 | |
| 82,737,000 | |
| 80,755,000 | |
| 60,538,000 | |
| 60,552,000 | |
| 120,033,000 | |
| 25,992,000 | |
| 75,244,000 | |
| 75,380,000 | |
| 75,381,000 | |
| 75,145,000 | |
| 105,150,000 | |
| 105,572,000 | |
| 106,653,000 | |
| 107,861,000 | |
| 108,105,000 | |
| 109,262,000 | |
| 110,213,000 | |
| 113,583,000 | |
| 112,636,000 | |
| 47,664,000 | |
| 51,817,000 | |
| 56,329,000 | |
| 52,171,000 | |
| 55,109,000 | |
| 57,197,000 | |
| 59,189,000 | |
| 59,868,000 | |
| 60,309,000 | |
| 56,088,000 | |
| 57,149,000 | |
| 58,202,000 | |
| 60,038,000 | |
| 60,411,000 | |
| 61,258,000 | |
| 1,143,000 | |
| 1,056,000 | |
| 917,000 | |
| 937,000 | |
| 994,000 | |
| 967,000 | |
| 872,000 | |
| 690,000 | |
| 629,000 | |
| 563,000 | |
| 510,000 | |
| 436,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |